S. Foley

Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-Hodgkin lymphoma

J. Kurtzberg, M. Cairo, J. Garvin, 2014, Leukemia.

A Phase I study of gemtuzumab ozogamicin (GO) in combination with busulfan and cyclophosphamide (Bu/Cy) and allogeneic stem cell transplantation in children with poor-risk CD33+ AML: a new targeted immunochemotherapy myeloablative conditioning (MAC) regimen.

Zhezhen Jin, M. Cairo, J. Garvin, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A low incidence of nontuberculous mycobacterial infections in pediatric hematopoietic stem cell transplantation recipients.

L. Saiman, M. Cairo, J. Garvin, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases

M. Cairo, J. Garvin, L. Baxter‐Lowe, 2007, Bone Marrow Transplantation.

Sequential administration of sargramostim and filgrastim in pediatric allogeneic stem cell transplantation recipients undergoing myeloablative conditioning †

M. Cairo, J. Garvin, L. Baxter‐Lowe, 2009, Pediatric transplantation.

Transplantation-related mortality, graft failure, and survival after reduced-toxicity conditioning and allogeneic hematopoietic stem cell transplantation in 100 consecutive pediatric recipients.

Zhezhen Jin, M. Cairo, J. Garvin, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

163: Systemic viral and fungal infections are not significantly decreased following reduced intensity allogeneic stem cell transplantation (RIAlloSCT) in children and adolescent recipients with malignant and nonmalignant diseases

M. Cairo, J. Garvin, M. Bhatia, 2007 .

Circulating hematopoietic stem cells serve as novel targets for in utero gene therapy

M. Bhatia, K. Chadwick, D. Hess, 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Planck early results Special feature Planck early results . III . First assessment of the Low Frequency Instrument in-flight performance

R. B. Barreiro, J. Tuovinen, F. Pasian, 2011 .